Contemporary Gender-Specific Outcomes in Germany after Radical Cystectomy for Bladder Cancer

Current Urology Reports

Volumn 15, Issue 6, 2014, Pages

  Schmid, Marianne ^a   Shariat, Shahrokh F ^b   Soave, Armin ^a   Engel, Oliver ^a   Fisch, Margit ^a   Rink, Michael ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^b MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Bladder cancer; Gender; Outcome; Prognosis; Urothelial carcinoma

Indexed keywords

CARCINOMA, TRANSITIONAL CELL; CYSTECTOMY; FEMALE; GERMANY; HUMAN; MALE; PATHOLOGY; PROCEDURES; SEX DIFFERENCE; TREATMENT OUTCOME; URINARY BLADDER NEOPLASMS;

CARCINOMA, TRANSITIONAL CELL; CYSTECTOMY; FEMALE; GERMANY; HUMANS; MALE; SEX FACTORS; TREATMENT OUTCOME; URINARY BLADDER NEOPLASMS;

EID: 84901582769     PISSN: 15272737     EISSN: 15346285     Source Type: Journal    
DOI: 10.1007/s11934-014-0409-2     Document Type: Review

References (74)

1. Siegel R, Naishadham D, Jemal A. Cancer statistics, 2013. CA Cancer J Clin. 2013;63(1):11-30.
2. Burger M, Catto J, Dalbagni G, et al. Epidemiology and risk factors of urothelial bladder cancer. Eur Urol. 2013;63:234-41.
3. Worlwide International Agency for Research on Cancer 2010, Lyon France, World Health Organisation: GLOBOCAN 2008, Cancer Incidence, Mortality, Prevalence and Disabiltity-adjusted life years (DALY's) in 2008.
4. Stenzl A, Cowan N, De Santis M, et al. Treatment of muscleinvasive and metastatic bladder cancer: update of the EAU guidelines. Eur Urol. 2011;59:1009-18.
5. Weisbach L, Dahlem R, Simone G, et al. Lymph node dissection during radical cystectomy for bladder cancer treatment: considerations on relevance and extent. Int Urol Nephrol. 2013.
6. Rink M, Cha EK, Green D, et al. Biomolecular predictors of urothelial cancer behavior and treatment outcomes. Curr Urol Rep. 2012;13(2):122-35.
7. Shariat SF, Karakiewicz PI, Palapattu GS, et al.Outcomes of radical cystectomy for transitional cell carcinoma of the bladder: a contemporary series from the Bladder Cancer Research Consortium. J Urol. 2006;176(6 Pt 1):2414-22. discussion 2422.
8. Fajkovic H, Halpern J, Cha E, et al. Impact of gender on bladder cancer incidence, staging, and prognosis. World J Urol. 2001;29:457-63.
9. Bochner B, Kattan M, Vora K, International Bladder Cancer Nomogram Consortium. Postoperative nomogram predicting risk of recurrence after radical cystectomy for bladder cancer. J Clin Oncol. 2006;4:3967-72. (Pubitemid 46630745)
10. Karakiewicz PI, Shariat SF, Palapattu GS, et al. Nomogram for predicting disease recurrence after radical cystectomy for transitional cell carcinoma of the bladder. J Urol. 2006;176(4 Pt 1):1354-61. discussion 1361-1352.
11. Vickers A, Cronin A, Kattan M, International Bladder Cancer Nomogram Consortium, et al. Clinical benefits of a multivariate prediction model for bladder cancer: a decision analytic approach. Cancer. 2009;115:5460-9.
12. Boström P, Alkhateeb S, Trottier G, et al. Sex differences in bladder cancer outcomes among smokers with advanced bladder cancer. BJU Int. 2012;109:70-6.
13. May M, Bastian PJ, Brookman-May S, et al. Gender-specific differences in cancer-specific survival after radical cystectomy for patients with urothelial carcinoma of the urinary bladder in pathologic tumor stage T4a. Urol Oncol. 2013;31(7):1141-7.
14. Mungan NA, Aben KK, Schoenberg MP, et al. Gender differences in stage-adjusted bladder cancer survival. Urology. 2000;55(6):876-80. (Pubitemid 30330791)
15. Mungan NA, Kiemeney LA, Van Dijck JA, et al. Gender differences in stage distribution of bladder cancer. Urology. 2000;55(3):368-71. (Pubitemid 30110586)
16. •• Otto W, May M, Fritsche H, et al. Analysis of sex differences in cancer-specific survival and perioperative mortality following radical cystectomy: results of a large German multicenter study of nearly 2500 patients with urothelial carcinoma of the bladder. Gend Med. 2012;9(6):481-9. This large study comprising 2,483 German patients demonstrates that female gender has an unfavorable impact on cancer-specific survival. Although the data in this study were collected retrospectively, the results have adequate strength due to the large study size. The data provide a basis to define suitable patient populations and allow an estimation of an adequate size of study cohorts for prospective studies.
17. Donsky H, Coyle S, Scosyrev E, Messing EM. Sex differences in incidence and mortality of bladder and kidney cancers: national estimates from 49 countries. Urol Oncol. 2013.
18. Shariat SF, Sfakianos JP, Droller MJ, et al. The effect of age and gender on bladder cancer: a critical review of the literature. BJU Int. 2010;105(3):300-8.
19. Wizemann T, Pardue M. Committee on understanding the biology of sex and gender differences: exploring the biological contributions to human health: does sex matter? J Women's Health Gend Based Med. 2001;10:433-9.
20. Ahmadi M, Ranjbaran H, Amiri MM, et al. Epidemiologic and socioeconomic status of bladder cancer in Mazandaran Province, northern Iran. Asian Pac J Cancer Prev. 2012;13(10):5053-6.
21. Jung K, Park S, Shin A, et al. Do female cancer patients display better survival rates compared with males? Analysis of the Korean National Registry data, 2005 -2009. PLoS One. 2012;7(12):e52457.
22. Najari B, Rink M, Li P, et al. Sex disparities in cancer mortality: the risks of being a man in the United States. J Urol. 2013;189(4):1470-4.
23. Underwood 3rd W, Dunn RL, Williams C, Lee CT. Gender and geographic influence on the racial disparity in bladder cancer mortality in the US. J Am Coll Surg. 2006;202(2):284-90. (Pubitemid 43112488)
24. Crow P, Ritchie AW. National and international variation in the registration of bladder cancer. BJU Int. 2003;92(6):563-6. (Pubitemid 37271730)
25. Rink M, Kluth L, Shariat S, et al. Use of PubMed to improve evidence-based medicine in routine urological practice. Urologe A. 2013;52(3):367-72.
26. Robert Koch Institut, Berlin, Germany: Krebs in Deutschland. Harnblase. (kid-2012-c67.pdf); 2012.
27. Kunath F, Keck B, Bertz S, et al. Is gender becoming relevant in uro-oncological research? A bibliographical analysis. World J Urol. 2013;31(5):1065-72.
28. Jemal A, Siegel R,Ward E, et al. Cancer statistics, 2008. CA Cancer J Clin. 2008;58(2):71-96. (Pubitemid 351521864)
29. Pou SA, Osella AR, Diaz Mdel P. Bladder cancer mortality trends and patterns in Cordoba, Argentina (1986-2006). Cancer Causes Control. 2011;22(3):407-15.
30. Datta G, Neville B, Datta N, Earle C. Gender disparities in bladder cancer survival: an assessment of sociodemographic factors. AACR Meeting, Abstracts 2006: B2038.
31. Scosyrev E, Noyes K, Feng C, Messing E. Sex and racial differences in bladder cancer presentation and mortality in the US. Cancer. 2009;115(1):68-74.
32. Tilki D, Reich O, Svatek RS, et al. Characteristics and outcomes of patients with clinical carcinoma in situ only treated with radical cystectomy: an international study of 243 patients. J Urol. 2010;183(5):1757-63.
33. Tilki D, Svatek RS, Karakiewicz PI, et al. Characteristics and outcomes of patients with pT4 urothelial carcinoma at radical cystectomy: a retrospective international study of 583 patients. J Urol. 2010;183(1):87-93.
34. Tilki D, Svatek RS, Novara G, et al. Stage pT0 at radical cystectomy confers improved survival: an international study of 4,430 patients. J Urol. 2010;184(3):888-94.
35. Madeb R, Messing EM. Gender, racial and age differences in bladder cancer incidence and mortality. Urol Oncol. 2004;22(2):86-92. (Pubitemid 38479800)
36. Robert Koch Institut, Berlin, Germany: Report: Cancer in Germany 2007/2008; 2012.
37. Nielsen ME, Smith AB, Meyer AM, et al. Trends in stage-specific incidence rates for urothelial carcinoma of the bladder in the United States: 1988 to 2006. Cancer. 2013.
38. Abdollah F, Gandaglia G, Thuret R, et al. Incidence, survival and mortality rates of stage-specific bladder cancer in United States: a trend analysis. Cancer Epidemiol. 2013;37(3):219-25.
39. Deutsches Krebsforschungszentrum, Heidelberg: Frauen und Rauchen in Deutschland; 2008.
40. Singer S, Ziegler C, Schwalenberg T, et al. Quality of life in patients with muscle invasive and non-muscle invasive bladder cancer. Support Care Cancer Off J Multinatl Assoc Support Care Cancer. 2013;21(5):1383-93.
41. •• May M, Stief C, Brookman-May S, et al. Gender-dependent cancer-specific survival following radical cystectomy. World J Urol. 2012;30(5):707-13. This German study of 521 UCB patients found that histopathological parameters did not differ significantly between genders. Interestingly, a reduced cancer-specific survival in women was present only in a historic subgroup of patients. Young female patients with positive LVI had significantly lower rates of CSS. These results demonstrate the current heterogeneity in findings.
42. • Jentzmik F, Schrader AJ, De Petriconi R, et al. The ileal neobladder in female patients with bladder cancer: long-term clinical, functional, and oncological outcome. World J Urol. 2012;30(6):733-9. This study provides information of good functional and oncological outcome of 121 female UCB patients who received an ileal neobladder at a German single-center.
43. Kubler H, Gschwend JE. Ileal neobladder in women with bladder cancer: cancer control and functional aspects. Curr Opin Urol. 2011;21(6):478-82.
44. Rink M, Chun FK, Chromecki TF, et al. Advanced bladder cancer in elderly patients. Prognostic outcomes and therapeutic strategies. Urologe A. 2012;51(6):820-8.
45. Rink M, Dahlem R, Kluth L, et al. Older patients suffer from adverse histopathological features after radical cystectomy. Int J Urol. 2011;18(8):576-84.
46. • Roghmann F, Trinh QD, Braun K, et al. Standardized assessment of complications in a contemporary series of European patients undergoing radical cystectomy. Int J Urol. 2013. This study assessed complications following RC in a contemporary series of 535 German patients.
47. Aziz A, Gierth M, Fritsche H, et al. Oncological outcome of primary versus secondary muscle-invasive bladder cancer is comparable after radical cystectomy. Urol Int. 2013;91(1):97-102.
48. Buchner A, May M, Burger M, et al. Prediction of outcome in patients with urothelial carcinoma of the bladder following radical cystectomy using artificial neural networks. Eur J Surg Oncol. 2013;39(4):372-9.
49. Fritsche HM, May M, Denzinger S, et al. Prognostic value of perinodal lymphovascular invasion following radical cystectomy for lymph node-positive urothelial carcinoma. Eur Urol. 2013;63(4):739-44.
50. Hautmann R, De Petriconi R, Pfeiffer C, Volkmer B. Radical cystectomy for urothelial carcinoma of the bladder without neoadjuvant or adjuvant therapy: long-term results in 1100 patients. Eur Urol. 2012;61(5):1039-47.
51. May M, Fritsche H, Gilfrich C, et al. Influence of older age on survival after radical cystectomy due to urothelial carcinoma of the bladder: survival analysis of a German multi-centre study after curative treatment of urothelial carcinoma of the bladder. Urologe A. 2011;50(7).
52. May M, Herrmann E, Bolenz C, et al. Association between the number of dissected lymph nodes during pelvic lymphadenectomy and cancer-specific survival in patients with lymph node-negative urothelial carcinoma of the bladder undergoing radical cystectomy. Ann Surg Oncol. 2011;18(7):2018-25.
53. Novotny V, Hakenberg OW, Froehner M, et al. Systematic assessment of complications and outcome of radical cystectomy undertaken with curative intent in patients with comorbidity and over 75 years of age. Urol Int. 2013;90(2):195-201.
54. Horstmann M, Witthuhn R, Falk M, Stenzl A. Gender-specific differences in bladder cancer: a retrospective analysis. Gend Med. 2008;5(4):385-94.
55. Soave A, Dahlem R, Hansen J, et al. Gender-specific outcomes after radical cystectomy: a contemprorary, homogenous bladder cancer cohort analyzed stage-by-stage. J Urol. 2013;189:667.
56. Shariat SF, Palapattu GS, Amiel GE, et al. Characteristics and outcomes of patients with carcinoma in situ only at radical cystectomy. Urology. 2006;68(3):538-42. (Pubitemid 44436492)
57. Lotan Y, Gupta A, Shariat SF, et al. Lymphovascular invasion is independently associated with overall survival, cause-specific survival, and local and distant recurrence in patients with negative lymph nodes at radical cystectomy. J Clin Oncol. 2005;23(27):6533-9. (Pubitemid 46190245)
58. Gierth M, Fritsche HM, Buchner H, et al. Clinical and pathological nodal staging score for urothelial carcinoma of the bladder: an external validation. World J Urol. 2013.
59. Shariat SF, Rink M, Ehdaie B, et al. Pathologic nodal staging score for bladder cancer: a decision tool for adjuvant therapy after radical cystectomy. Eur Urol. 2013;63(2):371-8.
60. Zeegers MP, Tan FE, Dorant E, Van Den Brandt PA. The impact of characteristics of cigarette smoking on urinary tract cancer risk: a meta-analysis of epidemiologic studies. Cancer. 2000;89(3):630-9. (Pubitemid 30640110)
61. Freedman N, Silverman D, Hollenbeck A, et al. Association between smoking and risk of bladder cancer among men and women. 2011;206(7):737-45.
62. Crivelli JJ, Xylinas E, Kluth LA, et al. Effect of smoking on outcomes of urothelial carcinoma: a systematic review of the literature. Eur Urol. 2013.
63. Rink M, Zabor EC, Furberg H, et al. Impact of smoking and smoking cessation on outcomes in bladder cancer patients treated with radical cystectomy. Eur Urol. 2013;64(3):456-64.
64. Okajima E, Hiramatsu T, Iriya K, et al. Effects of sex hormones on development of urinary bladder tumours in rats induced by N-butyl-N-(4- hydroxybutyl) nitrosamine. Urol Res. 1975;3(2):73-9.
65. Boorjian S, Ugras S, Mongan N. Androgen receptor expression is inversely correlated with pathologic tumor stage in bladder cancer. Urology. 2004;64:383-8. (Pubitemid 39092488)
66. Gakis G, Stenzl A. Gender-specific differences in muscle-invasive bladder cancer: the concept of sex steroid sensitivity. World J Urol. 2013;31(5):1059-64.
67. Miyamoto H, Yang Z, Chen YT, et al. Promotion of bladder cancer development and progression by androgen receptor signals. J Natl Cancer Inst. 2007;99(7):558-68. (Pubitemid 47078733)
68. Shen SS, Smith CL, Hsieh JT, et al. Expression of estrogen receptors-alpha and -beta in bladder cancer cell lines and human bladder tumor tissue. Cancer. 2006;106(12):2610-6.
69. Mcgrath M, Michaud DS, De Vivo I. Hormonal and reproductive factors and the risk of bladder cancer in women. Am J Epidemiol. 2006;163(3):236-44. (Pubitemid 43145751)
70. Johnson E, Daignault S, Zhang Y, Lee C. Patterns of hematuria referral to urologists: does a gender disparity exist? Urology. 2008;72:498-502.
71. Henning A, Wehrberger M, Madersbacher S, et al. Do differences in clinical symptoms and referral patterns contribute to the gender gap in bladder cancer? BJU Int. 2013;112(1):68-73.
72. Cardenas-Turanzas M, Cooksley C, Kamat AM, et al. Gender and age differences in blood utilization and length of stay in radical cystectomy: a population-based study. Int Urol Nephrol. 2008;40(4):893-9.
73. Taub DA, Hollenbeck BK, Cooper KL, et al. Racial disparities in resource utilization for cystectomy. Urology. 2006;67(2):288-93. (Pubitemid 43189843)
74. Siegrist T, Savage C, Shabsigh A, et al. Analysis of gender differences in early perioperative complications following radical cystectomy at a tertiary cancer center using a standardized reporting methodology. Urol Oncol. 2010;28(1):112-7.